- Home
- XFOR vs INBK Comparison
XFOR vs INBK Comparison
Compare XFOR & INBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | XFOR | INBK |
|---|---|---|
| Founded | 2014 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 288.5M | 255.0M |
| IPO Year | 2017 | 2013 |
Fundamental Metrics
Financial Performance| Metric | XFOR | INBK |
|---|---|---|
| Price | $3.17 | $25.43 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 5 | 4 |
| Target Price | $11.60 | ★ $31.00 |
| AVG Volume (30 Days) | ★ 646.1K | 36.6K |
| Earning Date | 11-04-2026 | 10-29-2026 |
| Dividend Yield | N/A | ★ 0.93% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 1.10 |
| Revenue | $6,500,000.00 | ★ $11,541,000.00 |
| Revenue This Year | N/A | $18.83 |
| Revenue Next Year | N/A | $12.94 |
| P/E Ratio | ★ N/A | $24.66 |
| Revenue Growth | ★ 150.00 | 101.84 |
| 52 Week Low | $2.43 | $17.05 |
| 52 Week High | $4.83 | $31.09 |
Technical Indicators
Market Signals| Indicator | XFOR | INBK |
|---|---|---|
| Relative Strength Index (RSI) | 50.33 | 45.45 |
| Support Level | $2.83 | $25.08 |
| Resistance Level | $3.52 | $26.47 |
| Average True Range (ATR) | 0.26 | 0.93 |
| MACD | 0.02 | 0.01 |
| Stochastic Oscillator | 53.47 | 30.94 |
Price Performance
Historical ComparisonAbout XFOR X4 Pharmaceuticals Inc.
X4 Pharmaceuticals Inc is a biopharmaceutical company developing and commercializing novel therapeutics for the treatment of rare hematology diseases. The Company's clinical candidate is mavorixafor, a small molecule antagonist of the chemokine receptor CXCR4 that is being developed as an oral, once-daily therapy. It can increase the mobilization of mature, functional white blood cells from the bone marrow into the bloodstream. It also has two pre-clinical candidates X4P-003 and X4P-002 which are CXCR4 antagonists with different properties.
About INBK First Internet Bancorp
First Internet Bancorp is a bank holding company. Through its subsidiaries, it provides commercial real estate (CRE) lending, including nationwide single tenant lease financing and commercial and industrial (C&I) lending, including business banking or treasury management services. The company offers its products and services through the internet and does not have any branches. With operations organized into a single segment called the Commercial Banking segment, it also provides retail banking services.